Jessica Hopfield, Director at Editas Medicine, Inc. (EDIT), bought 45,000 shares at $5.64 ($254K) on 2024-05-13, disclosed to the SEC on 2024-05-14.
Open-market purchase of $254k EDIT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| BLI | BUY | 2022-03-11 | $502K | — | Filing → |
| EDIT | BUY | 2021-03-05 | $264K | — | Filing → |
| MRVI | BUY | 2020-11-25 | $1.4M | — | Filing → |